Cargando…
Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer
Chemotherapy, targeted therapy, and immunotherapy are used against advanced non-small cell lung cancer. A clinically efficacious method for relieving the adverse events associated of such therapies is lacking. Fifty-eight adult patients were enrolled in our trial to relieve pulmonary symptoms or the...
Autores principales: | Chen, Ji-Bing, Kong, Xiao-Feng, Mu, Feng, Lu, Tian-Yu, Lu, You-Yong, Xu, Ke-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885710/ https://www.ncbi.nlm.nih.gov/pubmed/32541132 http://dx.doi.org/10.4103/2045-9912.285560 |
Ejemplares similares
-
Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study
por: Chen, Ji-Bing, et al.
Publicado: (2020) -
“Real world survey” of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients
por: Chen, Ji-Bing, et al.
Publicado: (2019) -
High-flow hydrogen inhalation might suppresses the immune function of middle-aged participants: a self-controlled study
por: Chen, Ji-Bing, et al.
Publicado: (2021) -
A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation
por: Chen, Jibing, et al.
Publicado: (2019) -
A narrative review of hydrogen oncology: from real world survey to real world evidence
por: Chen, Ji-Bing, et al.
Publicado: (2020)